NCT02233647View on ClinicalTrials.gov

Phendimetrazine and Cocaine

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Cocaine Use Disorder
Interventions
DRUG

Cocaine

The pharmacodynamic effects of cocaine will be determined during maintenance on placebo and phendimetrazine.

DRUG

Placebo

The pharmacodynamic effects of placebo will be determined during maintenance on placebo and phendimetrazine.

Trial Locations (1)

40507

University of Kentucky Laboratory of Human Behavioral Pharmacology, Lexington

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

William Stoops

OTHER

NCT02233647 - Phendimetrazine and Cocaine | Biotech Hunter | Biotech Hunter